Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
DNDi Drugs for Neglected Diseases initiative
DNDi Drugs for Neglected Diseases initiative
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
Bayer and DNDi to develop oral treatment for human river blindness
German healthcare giant will provide active ingredient emodepside which shows potential as a macrofilaricidal drug
Research & Development
Old drug shows new promise to treat leishmaniasis
University of Dundee scientists study fexinidazole
Research & Development
Drug companies join forces to end neglected tropical diseases
Will expand drug donation programmes and provide US$785m to support r&d efforts
Research & Development
Sanofi and DNDi sign research collaboration deal
To generate new drugs for Neglected Tropical Diseases
Regulatory
Pfizer and DNDi enter tropical disease partnership
To support the development of improved treatments for neglected African diseases
Sustainability
Consortium to develop drugs for neglected tropical diseases
<p>A consortium has been formed to develop drugs for the treatment of African sleeping sickness and Leishmaniasis, which affect millions of people worldwide. </p>
Research & Development
Merck & Co and DNDi collaborate to find treatments for world's most neglected tropical diseases
To develop improved treatments for NTDs such as visceral leishmaniasis and Chagas disease
Subscribe now